It will soon be time for community pharmacy owners to verify their NHS Profile Manager profile information. Ahead of the 30th June 2023 deadline, we would like to remind members of the need for you to update NHS Profile Manager to ensure that your pharmacy’s NHS website and Directory of Services (DoS) profile information is kept up-to-date. [...]
The post NHS Profile Manager: Spring reminder appeared first on PSNC Website.
Contractors (including head office staff) and community pharmacists have one month left to participate in an interview to share their views on the Quality Payments Scheme (QPS) (the previous name for the Pharmacy Quality Scheme (PQS)) and the PQS. ICF (an independent research consultancy) and the University of Manchester are carrying out the evaluation. The [...]
The post Evaluation of the QPS and PQS – one month left to share your views appeared first on PSNC Website.
The Department of Health and Social Care (DHSC) has today (24/05/2023) granted the following list of price concessions for May 2023: Drug Pack size Price concession Amoxicillin 125mg/5ml oral suspension sugar free 100 £3.42 Amoxicillin 250mg/5ml oral suspension sugar free 100 £3.50 Atorvastatin 20mg tablets 28 £1.56 Bimatoprost 100micrograms/ml eye drops 3 £3.99 Clarithromycin 250mg/5ml oral [...]
The post May 2023 Price Concessions 2nd Update appeared first on PSNC Website.
Class 4 Medicines Defect Information: Metronidazole 200 mg/5 ml Oral Suspension (Drugsrus Limited / Dawa Limited) Drug alert number: EL (23)A/19 Date issued: 23 May 2023 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 4 medicines defect information notice for: Product name:Metronidazole 200 mg/5 ml Oral Suspension, PL 30684/0236 Batch No [...]
The post Class 4 Medicines Defect Information: Metronidazole 200 mg/5 ml Oral Suspension (Drugsrus Limited / Dawa Limited) appeared first on PSNC Website.
Class 4 Medicines Defect Information: Buccolam 10mg Oromucosal solution (Orifarm UK Ltd) Drug alert number: EL (23)A/18 Date issued: 22 May 2023 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 4 medicines defect information notice for: Product name: Buccolam 10mg Oromucosal solution (Orifarm UK Ltd) PLGB 45985/0272 Batch No Expiry Date [...]
The post MHRA Class 4 Medicines Defect Information: Buccolam 10mg Oromucosal solution (Orifarm UK Ltd) appeared first on PSNC Website.
Recent Comments